We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Siemens Healthineers Launches Thermocycler with AI-Powered Software

By LabMedica International staff writers
Posted on 26 Apr 2018
Siemens Healthineers (Erlangen, Germany) launched a new molecular thermocycler, the Fast Track cycler (FTC), and the complementary new FastFinder software at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018). More...
The compact FTC allows laboratories of all sizes to implement molecular testing with simplicity and speed, while the FastFinder software improves workflow using Artificial Intelligence (AI)-powered automation.

Weighing two kilograms and measuring 150 mm x 150 mm x 130 mm, the FTC is a scalable platform, allowing up to 10 thermocyclers to be connected to one computer and permitting laboratories to utilize a range of 1 to 480 wells. The FTC uses magnetic induction technology to deliver robust and reliable results, and does not require calibration, as a result of which it does not drift or age and offers simple handling. The FTC is also equipped with the Fast Track lyophilised technology, offering reagents for PCR experiments in a single sample tube, simplifying processes for users by eliminating the need to prepare the reaction mix before test implementation. The technology allows users to simply add nucleic acid extracts to the prepared tubes before inserting into the cycler.

Siemens Healthineers, in collaboration with UgenTec, also launched FastFinder software, which is a fully automated real-time PCR interpretation platform that is compatible with all multiplexing kits from Fast Track Diagnostics. The software allows users to fully automate and standardize analysis of kits with the Applied Biosystems 7500 and LightCycler 480 PCR platforms. FastFinder uses its built-in statistical machine learning models to accurately analyze every amplification curve, then automatically combines these results and processes them through an assay-specific decision tree, leading to overall and conclusive results.

With automated plate detection, Laboratory Information Management System (LIMS) connection, and a user-friendly interface, FastFinder is easy-to-use and requires limited training. All assay parameters come pre-set for speed and ease of implementation, and clear, customizable reports allow easy reading of results. The audit trail of analysis, integrated archive, and simultaneous analysis of multiple run files results in improved monitoring and enables users to provide patients with the relevant treatment more quickly.

“Enabled by AI, FastFinder software minimizes the need for manual processing, which not only saves time, but increases the reliability of results as well,” said Fernando Beils, Head of Molecular Diagnostics, Siemens Healthineers. “Users receive 100% reproducible results in a matter of seconds, improving laboratory workflows and expanding precision medicine."

"Siemens Healthineers' focus on AI aligns perfectly with our vision for FastFinder. The combination of Siemens Healthineers' hardware and assays and our extensible software will guide laboratories globally to simple, accurate, and automated molecular diagnostics," said Steven Verhoeven, CEO at UgenTec.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Gold Member
Platelet Function Analyzer
PL-12
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.